Business Update Neutral

2026-11-05 17:45

- Audio recording of the Earnings Conference Call held on November 05, 2026, is made available on the company's website. - The call covered Unaudited Standalone & Consolidated Financial Results for Q2 and H1 ended September 30, 2026.

Business Update Neutral

2026-11-05 17:32

- Audio recording of the Earnings Conference Call held on November 05, 2026, is available on the Company's website. - The call covered Unaudited Standalone and Consolidated Financial Results for Q2 and H1 ended September 30, 2026.

Business Update Negative

2026-11-04 22:46

- Q2 FY27 Consolidated Revenue fell 9% YoY to ₹17,018 Mn. - EBITDA declined 57% YoY to ₹2,362 Mn; PAT dropped 70% YoY to ₹1,222 Mn. - Agchem exports fell ~18% due to global genericization and pricing pressure. - Domestic revenue grew 19% and Global Biologicals surged over 250%.

Business Update Negative

2026-11-04 22:45

- Q2 FY27 Consolidated Revenue fell 9% YoY to ₹1,701.8 Cr; EBITDA dropped 57% to ₹236.2 Cr. - Net Profit declined 70% YoY to ₹122.2 Cr due to global Agchem export headwinds and pricing pressure. - Domestic revenue grew 19% YoY, while global biologicals surged over 250%. - H1 FY27 capex stood at ₹567.4 Cr with surplus cash of ₹3,573.7 Cr.

Financials Neutral

2026-11-04 19:54

Q2 FY27 Consolidated Revenue ₹1,702Cr vs ₹1,872Cr (▼9% YoY) EBITDA ₹236Cr vs ₹543Cr (▼57% YoY) PAT ₹122Cr vs ₹409Cr (▼70% YoY) EBITDA Margin 13.9% vs 29.0% (▼1514bps)

Financials Negative

2026-11-04 19:52

Q2 FY27 Consolidated Revenue ₹1,702Cr vs ₹1,872Cr (▼9% YoY) EBITDA ₹236Cr vs ₹543Cr (▼57% YoY) PAT ₹122Cr vs ₹409Cr (▼70% YoY) EBITDA Margin 13.9% vs 29.0% (▼1514bps)

Financials Negative

2026-11-04 19:52

Q2 FY27 Consolidated Revenue ₹1,701.8 Cr vs ₹1,872.3 Cr (▼9.1% YoY) EBITDA ₹236.2 Cr vs ₹543.4 Cr (▼56.5% YoY) PAT ₹122.2 Cr vs ₹409.3 Cr (▼70.1% YoY) EBITDA Margin 13.9% vs 29.0% (▼1514bps)

Business Update Positive

2026-10-29 18:39

PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule. - Developed through over a decade of original research, investment, and scientific innovation. - Received registration from the Central Insecticides Board and Registration Committee (CIB&RC). - Marks a major milestone in India's agricultural science and proprietary innovation capabilities.

Business Update Positive

2026-10-29 18:29

PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule. - Developed through over a decade of research, it has received registration from CIB&RC. - The milestone strengthens the company's innovation pipeline and scientific capabilities in agricultural science.

Business Update Neutral

2026-10-27 18:54

Concall Schedule Concall Date: November 05, 2026 Concall Time: 12:00 noon IST

Business Update Neutral

2026-10-27 18:49

Concall Schedule Concall Date: Thursday, November 5, 2026 Concall Time: 12:00 noon (IST)

Business Update Neutral

2026-10-27 18:41

Concall Schedule Concall Date: November 5, 2026 Concall Time: 12:00 noon IST

Business Update Neutral

2026-10-27 18:37

Concall Schedule Concall Date: November 5, 2026 Concall Time: 12:00 noon IST

Governance Neutral

2026-10-27 18:29

- Board Meeting scheduled on Wednesday, November 4, 2026. - To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. - Trading window closure in effect from October 1, 2026, to November 6, 2026.

Business Update Neutral

2026-10-19 18:49

- PI Industries Limited has incorporated a wholly owned subsidiary named "PI Foundation" under Section 8 of the Companies Act, 2013 on October 19, 2026. - The new entity will serve as a not-for-profit organisation to carry out Corporate Social Responsibility (CSR) activities. - The initial share capital subscription is ₹1,00,000 in cash.

Business Update Neutral

2026-10-19 18:48

- PI Industries Limited has successfully incorporated a wholly owned subsidiary named "PI Foundation" on October 19, 2026. - The subsidiary is established as a not-for-profit organization under Section 8 of the Companies Act, 2013, to carry out CSR activities. - Initial cash subscription for the share capital is ₹1,00,000.

Routine Neutral

2026-09-25 11:10

- Trading window for dealing in company securities will close from Thursday, October 1, 2026. - Closure applies to all Designated Persons and their immediate relatives. - Reopens 48 hours after declaration of Q2/quarter ending September 30, 2026 financial results.

Routine Neutral

2026-09-25 11:09

- Trading window for Designated Persons and immediate relatives closed from October 1, 2026. - Closure will remain effective until 48 hours after declaration of Q2 financial results ending September 30, 2026. - Date of results declaration to be communicated in due course.

Business Update Positive

2026-09-21 18:51

- PI Industries Limited received registration for 'Pioxaniliprole', branded 'Pioxazon', India's first indigenously discovered insecticide. - Registered under section 9(3) of the Insecticides Act, 1968, it caters to the domestic market and will be launched soon. - This marks a significant milestone in the country's agricultural innovation journey.

Business Update Positive

2026-09-21 18:41

- PI Industries Limited received registration for 'Pioxaniliprole' (branded 'Pioxazon'), India's first indigenously discovered insecticide, on September 21, 2026. This breakthrough product is an insecticide for the domestic market and will be launched soon.

Business Update Neutral

2026-09-18 17:21

- Investor Meeting Schedule - Meeting Date: September 23, 2026 - Investor/Event: UTI Mutual Fund (One-on-One) - Venue: Mumbai - No unpublished price sensitive information to be shared.

Business Update Neutral

2026-09-18 16:48

- Investor/Analyst Interaction Schedule - Date: September 23, 2026 - Interacting with: UTI Mutual Fund (One-on-One)

Business Update Neutral

2026-09-03 13:17

- PI Industries Limited will interact with analysts/investors on September 9, 2026. - One-on-one meetings are scheduled with ASK Investment Managers, Kotak Institutional Equities, and Canara HSBC Life Insurance in Mumbai. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-09-03 13:14

- PI Industries Limited will conduct one-on-one meetings with ASK Investment Managers, Kotak Institutional Equities, and Canara HSBC Life Insurance on September 9, 2026, in Mumbai. - No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-08-31 17:52

- Intimation of interaction with Analysts/Investors as per Regulation 30(6) of SEBI (LODR) Regulations, 2015. - Meetings scheduled: - September 3, 2026: One-on-One meeting with Fortitude Fund Management LLP in Mumbai. - September 9, 2026: One-on-One meeting with Aberdeen in Mumbai. - September 10, 2026: One-on-One meeting with Kotak Mutual Fund in Mumbai. - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-08-31 17:50

- Investor/Analyst Interactions Scheduled: - September 3, 2026: One-on-One meeting with Fortitude Fund Management LLP. - September 9, 2026: One-on-One meeting with Aberdeen. - September 10, 2026: One-on-One meeting with Kotak Mutual Fund. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-31 17:47

- Investor/Analyst Meetings Schedule: - September 3, 2026: Fortitude Fund Management LLP - September 9, 2026: Aberdeen - September 10, 2026: Kotak Mutual Fund - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-31 17:46

- Investor Meetings Schedule - Meetings with Analysts/Investors on: - September 3, 2026: Fortitude Fund Management LLP - September 9, 2026: Aberdeen - September 10, 2026: Kotak Mutual Fund - No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-08-31 17:44

- Intimation for interaction with Analysts/Investors. - Meetings scheduled: - September 3, 2026: Fortitude Fund Management LLP (One-on-One) - September 9, 2026: Aberdeen (One-on-One) - September 10, 2026: Kotak Mutual Fund (One-on-One) - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-08-31 17:41

- Investor Meetings Scheduled by PI Industries Limited for September 2026 - September 3, 2026: One-on-One with Fortitude Fund Management LLP - September 9, 2026: One-on-One with Aberdeen - September 10, 2026: One-on-One with Kotak Mutual Fund - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-08-26 17:19

- Investor Meeting Schedule - Meeting Date: August 31, 2026 - Investor/Analyst: ITUS Capital - Type: One-on-One, Virtual - No unpublished price sensitive information (UPSI) will be shared.

Business Update Neutral

2026-08-26 17:16

- Investor Meeting Schedule - Date: August 31, 2026 - Investor/Analyst: ITUS Capital - Type: Virtual One-on-One - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-19 17:47

- Investor Meetings Schedule - August 25, 2026: Meeting with Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Meeting with Quest Investments (Mumbai, One-on-One) - September 04, 2026: Meeting with Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-08-19 17:45

- Investor/Analyst Meetings Scheduled: - August 25, 2026: Virtual one-on-one meeting with Kotak Mahindra Asset Management Company. - August 31, 2026: One-on-one meeting in Mumbai with Quest Investments. - September 04, 2026: One-on-one meeting in Mumbai with Awriga Capital. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-19 17:44

- Intimation for interaction with Analysts/Investor(s) - Meetings scheduled: - August 25, 2026: Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Quest Investments (Mumbai, One-on-One) - September 04, 2026: Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-19 17:41

- PI Industries Limited will interact with analysts/investors on the following dates: - August 25, 2026, with Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026, with Quest Investments (Mumbai, One-on-One) - September 04, 2026, with Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information is proposed to be shared during these meetings.

Business Update Neutral

2026-08-19 17:39

- Investor Meetings Scheduled: - August 25, 2026: One-on-one meeting with Kotak Mahindra Asset Management Company (Virtual). - August 31, 2026: One-on-one meeting with Quest Investments (Mumbai). - September 04, 2026: One-on-one meeting with Awriga Capital (Mumbai). - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-08-19 17:35

- Analyst/Investor Interactions Scheduled: - August 25, 2026: Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Quest Investments (Mumbai, One-on-One) - September 04, 2026: Awriga Capital (Mumbai, One-on-One) - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Positive

2026-08-18 20:45

- Q1 FY27 Reported Revenue: ₹17,023 million with a gross margin of 57% and EBITDA margin of 22%. - Domestic agri business achieved 12% volume growth in Q1 FY27, including 50% growth in biologicals, leading to 3% revenue growth despite initial market challenges. - FY27 Outlook: Expects FY27 to be better than FY26, driven by H2 export recovery, new product launches, and scale-up in pharma and global biologicals businesses. Revenue growth projected in the "lower single digit" positive trajectory. - Strategic Investments: Significant R&D investments (3-4% of revenue) and capital expenditure (FY27 guidance ₹700-800 crore) for new verticals, innovation, and existing manufacturing. - Growth Initiatives: Expanding global biologicals, launching unique foliar application nematicide in Brazil, Mexico, and US. First NCE, Pioxaniliprole (insecticide), expected for domestic launch soon, with 4-5 new molecule launches planned for FY27 across various segments. - Financial Strength: Strong debt-free balance sheet with ₹38 billion net cash; reduced net working capital by 19 days, releasing ₹300 crore cash. - Margin Management: Facing margin pressure from high input costs and inventory but focused on optimization to maintain targeted gross margins.

Business Update Positive

2026-08-18 20:42

- The company reported Q1 FY27 Revenue of ₹17,023 million with a gross margin of 57% and EBITDA of 22% (₹3,693 million). - FY27 revenue growth guidance is in the lower single digits, with an expected Effective Tax Rate (ETR) of around 24%. - Capex guidance for FY27 is ₹700-₹800 crore. - Management expects FY27 to be better than FY26, driven by recovery in exports in H2, new product launches, and gradual scale-up of pharma and global biologicals businesses. - Biologicals business showed 50% aggressive growth in Q1, with a 3-year CAGR of 15%, and is launching new nematicide products in Brazil, Mexico, and the US (Brazil market estimated at ~USD 750 million). - New NCE, Pioxaniliprole (an insecticide), is expected to launch in the domestic market this year, with plans for other geographies later. Dicloromezotiaz is also launching this season with long-term 3-digit revenue potential in India. - Strategic investments in new businesses like Pharma (CRDMO) and Global Biologicals are leading to current subsidiary losses (approx. ₹100 crore EBITDA loss in Q1) but are considered vital for future long-term growth and value creation. - The company maintains a strong, debt-free balance sheet with ₹38 billion in net cash, and reduced net working capital by 19 days, releasing ₹300 crore in cash. - Electronic and specialty chemicals segment shows continued trajectory with new queries and commercialization, with commercial supplies now started with new technology.

Governance Neutral

2026-08-14 18:20

CRITICAL RED FLAG DETECTED

- PI Industries' 79th AGM held August 14, 2026. - Total dividend of ₹15.00 per share for FY26 declared. - Mr. Rajnish Sarna stepped down as JMD, continues as Non-executive Director. - Mr. Arvind Singhal did not seek re-appointment as Non-Executive Director.

Governance Neutral

2026-08-14 18:16

CRITICAL RED FLAG DETECTED

- PI Industries' 79th AGM held August 14, 2026. - All 9 business items passed, including FY2025-26 financials and ₹15/share dividend. - Joint MD Rajnish Sarna stepped down; Non-Executive Director Arvind Singhal not re-appointed. - Management confident in future growth and industry recovery.

Business Update Neutral

2026-08-13 18:41

- Investor/Analyst Interactions Scheduled - Date & Firm (1): August 19, 2026 with DSP Asset Managers (Mumbai, One-on-One) - Date & Firm (2): August 24, 2026 with Capital World (Virtual, One-on-One) - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-08-13 18:32

- Investor Interactions Schedule - August 19, 2026: One-on-One meeting with DSP Asset Managers (Mumbai) - August 24, 2026: One-on-One virtual meeting with Capital World - No unpublished price sensitive information to be shared during these interactions.

Business Update Neutral

2026-08-13 18:31

- PI Industries Limited will interact with analysts/investors on August 19, 2026 (DSP Asset Managers in Mumbai) and August 24, 2026 (Capital World virtually). - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-13 18:30

- Investor/Analyst Interactions Scheduled - Concall Date: August 19, 2026 - Concall Type: One-on-One meeting with DSP Asset Managers (Mumbai) - Concall Date: August 24, 2026 - Concall Type: One-on-One virtual meeting with Capital World - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-12 16:50

- Concall Schedule - Concall Date: August 19, 2026

Business Update Neutral

2026-08-12 16:47

- Investor Meet Schedule - Date: August 19, 2026 - Event: Motilal Oswal 22nd Annual Global Investor Conference, 2026 - Meeting Type: Mix of One-on-One and Group Meetings

Business Update Neutral

2026-08-12 16:41

- Audio recording of the Earnings Conference Call for the quarter ended June 30, 2026, is now available. It discusses the unaudited standalone & consolidated financial results. The call was held on August 12, 2026, and the recording is accessible on the company's website.

Business Update Neutral

2026-08-12 16:39

- Audio recording of the Earnings Conference Call for the quarter ended June 30, 2026, is available on the company's website. - The conference call was held on Wednesday, August 12, 2026.

Financials Negative

2026-08-11 21:22

- Q1 FY27 Consolidated Revenue ₹17,023 Mn vs ₹19,005 Mn (▼10% YoY) - EBITDA ₹3,693 Mn vs ₹5,219 Mn (▼29% YoY) - PAT ₹2,442 Mn vs ₹4,000 Mn (▼39% YoY) - EBITDA Margin 22% vs 27% (▼577bps)

Financials Negative

2026-08-11 21:21

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29% YoY) - PAT ₹244.2Cr vs ₹400Cr (▼39% YoY) - EBITDA Margin 22% vs 27% (▼577bps) - Domestic Biologicals grew 50%+ YoY in Q1FY27 - Commercialized 3 new molecules in Exports and launched a new peptide-based Biological product in the US - Trade Working Capital reduced by 19 Days to 120 Days in Jun-26 - Net Cash balance increased to INR 37,939 Mn

Financials Negative

2026-08-11 19:36

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.43% YoY) - EBITDA ₹3,693Mn vs ₹5,219Mn (▼29.24% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps) - The Board also approved the incorporation of a Wholly Owned Subsidiary, 'PI Foundation', under Section 8 of the Companies Act, 2013.

Financials Negative

2026-08-11 19:35

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10.43% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29.24% YoY) - PAT ₹244.2Cr vs ₹400.0Cr (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps)

Financials Negative

2026-08-11 19:23

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.43% YoY) - EBITDA ₹4,334Mn vs ₹6,078Mn (▼28.70% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 25.46% vs 31.98% (▼652bps) - The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. - The Board also approved the incorporation of 'PI Foundation' as a Wholly Owned Subsidiary of the Company.

Financials Negative

2026-08-11 19:16

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.42% YoY) - EBITDA ₹4,334Mn vs ₹6,078Mn (▼28.69% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 25.46% vs 31.98% (▼652bps) - Board approved the incorporation of PI Foundation as a wholly-owned subsidiary for CSR activities, with an initial share capital of ₹1,00,000/-.

Financials Negative

2026-08-11 19:07

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10.43% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29.24% YoY) - PAT ₹244.2Cr vs ₹400.0Cr (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps)

Business Update Neutral

2026-08-03 19:17

- Concall Schedule - Concall Date: August 12, 2026 - Concall Time: 12:00 noon IST

Business Update Neutral

2026-08-03 19:16

- Concall Schedule - Concall Date: August 12, 2026 - Concall Time: 12:00 noon IST

Governance Neutral

2026-08-03 19:13

- Board Meeting on August 11, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. - Trading window closed from July 1, 2026, to August 13, 2026.

Governance Neutral

2026-07-21 17:45

- Intimation regarding the 79th Annual General Meeting (AGM). - AGM scheduled for August 14, 2026, at 10:30 A.M. (IST) via VC/OAVM. - Web-links for the AGM notice and FY 2025-26 Integrated Annual Report shared with shareholders.

Governance Neutral

2026-07-21 17:41

- PI Industries Ltd. has intimated the scheduling of its 79th Annual General Meeting (AGM) on August 14, 2026, at 10:30 A.M. IST via Video Conferencing/Other Audio-Visual Means. - Shareholders are informed about accessing the Notice of AGM and the Integrated Annual Report for FY 2025-26 electronically.

Governance Positive

2026-07-20 15:26

- Submission of Integrated Annual Report for FY 2025-26 and Notice for 79th Annual General Meeting (AGM). - AGM scheduled for August 14, 2026, at 10:30 a.m. (IST) via Video Conferencing. - Record date for dividend entitlement is August 7, 2026. - Proposed final dividend of Rs. 10/- per equity share for FY 2025-26, if declared at the AGM.

Financials Positive

2026-07-20 15:23

- Integrated Annual Report for the financial year 2025-26 submitted. - 79th Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:30 a.m. (IST) via VC/OAVM. - Record Date for determining dividend entitlement fixed as August 7, 2026. - Final dividend of ₹10/- per equity share proposed for FY 2025-26, subject to AGM declaration.

Routine Negative

2026-07-20 15:13

CRITICAL RED FLAG DETECTED

- Filed Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per SEBI (LODR) Regulations. - The report details the company's sustainability initiatives, governance frameworks, and ESG performance. - A monetary penalty of ₹30.03 lakhs was imposed by the Excise and Taxation Officer for FY 2021-22 (GST input tax credits), which is currently under dispute.

Governance Positive

2026-07-20 14:57

- Submission of Integrated Annual Report for FY 2025-26. - 79th Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:30 a.m. (IST). - Record Date for dividend entitlement is August 7, 2026. - Final dividend of ₹10/- per equity share for FY 2025-26 proposed, subject to AGM approval.

Governance Positive

2026-07-16 19:46

- 79th Annual General Meeting (AGM) scheduled for August 14, 2026. - Record Date for final dividend of ₹10/- per equity share for FY 2025-26 (if declared) is August 7, 2026.

Financials Positive

2026-07-16 19:36

- 79th Annual General Meeting (AGM) scheduled for August 14, 2026. - Record Date for final dividend of ₹10/- per equity share for FY 2025-26 is August 7, 2026.

Governance Positive

2026-07-16 19:28

- 79th Annual General Meeting (AGM) of the Company is scheduled for Friday, August 14, 2026. - The Record Date for determining entitlement to receive the final dividend of ₹10/- per equity share for FY 2025-26 is Friday, August 7, 2026.

Governance Positive

2026-07-16 19:11

- Intimation of 79th AGM on August 14, 2026, through VC/OAVM. - Record Date for final dividend of Rs. 10/- per equity share for FY 2025-26 is August 7, 2026, if declared at AGM.

Routine Neutral

2026-06-26 15:00

- The trading window for dealing in the Company's securities will remain closed for all Designated Persons and their immediate relatives from July 1, 2026. - It will reopen 48 hours after the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026, are made public.

Routine Neutral

2026-06-26 14:58

- Intimation for closure of trading window for designated persons. - Effective from July 1, 2026, until 48 hours after Q1 FY27 results. - Ahead of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Business Update Positive

2026-06-23 19:46

- PI Industries' Board approved converting ₹10,000 Cr worth of Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72,46,37,681 equity shares. This strengthens the consolidated balance sheet without changing PIHS's ownership or control.

Business Update Positive

2026-06-23 19:39

- PI Industries' Board approved converting ₹10,000 Cr Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72.46 Cr equity shares at ₹13.80/share. The conversion aims to strengthen the consolidated balance sheet and involves no cash.

Business Update Positive

2026-06-23 19:39

- PI Industries' Board approved the conversion of ₹10,000 million worth of Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72,46,37,681 equity shares at ₹13.80/share. - This conversion strengthens the consolidated balance sheet and does not alter the ownership or control of PIHS, which remains a wholly-owned subsidiary.

Business Update Neutral

2026-06-18 16:20

- PI Industries Limited announced interactions with analysts and investors. - Meetings scheduled for June 23, 2026, with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Additional investor meetings are scheduled for June 25 and June 26, 2026, in Singapore. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-18 16:17

- PI Industries Limited will interact with analysts/investors on June 23, 2026, and June 25-26, 2026. - Meetings include Ellerston Capital, JM Financial Institutional Securities, and general investor meetings in Virtual, Mumbai, and Singapore. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-18 16:13

- PI Industries Limited will interact with analysts/investors on June 23, 2026, including Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Further investor meetings are scheduled in Singapore on June 25 and June 26, 2026. - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-06-18 16:10

- The company has scheduled interactions with Analysts/Investors. - June 23, 2026: One-on-one meetings with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - June 25-26, 2026: Investor meetings in Singapore (mix of one-on-one and group). - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-06-18 16:06

- Intimation of interactions with Analysts/Investors as per Regulation 30(6) of SEBI (LODR) Regulations, 2015. - Meetings scheduled for June 23, 2026, with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Additional investor meetings scheduled for June 25 and June 26, 2026, in Singapore. - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-06-18 16:04

- PI Industries will interact with analysts/investors from Ellerston Capital, JM Financial, and other investors on June 23, 25, and 26, 2026, in one-on-one and group formats. No price sensitive information will be shared.

Business Update Neutral

2026-06-16 17:57

- Schedule of Investor/Analyst Interactions - Date: June 22, 2026 - Interactions with: Enam AMC, ADD Capital, Capital Group (London), Franklin Templeton MF (all one-on-one) - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-16 17:56

- PI Industries Limited will be interacting with analysts/investors on June 22, 2026. - Scheduled one-on-one meetings with Enam AMC, ADD Capital, Capital Group (London), and Franklin Templeton MF. - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-06-11 13:23

- Investor/Analyst Meetings Scheduled - Meeting Date: June 16, 2026 - Participants: Nuvama Institutional Equities, Keynote Financial Services Ltd. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-11 13:19

- Investor/Analyst Meetings Schedule - Date: June 16, 2026 - Company representatives to interact with Nuvama Institutional Equities and Keynote Financial Services Ltd in one-on-one meetings.

Business Update Neutral

2026-06-02 15:53

- Investor/Analyst Meetings Schedule - June 5, 2026: One-on-One meeting with Morgan Stanley in Mumbai. - June 12, 2026: One-on-One meeting with Bank of America Securities in Mumbai. - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Neutral

2026-06-02 15:49

- Investor Interactions Scheduled - June 5, 2026: One-on-One meeting with Morgan Stanley - June 12, 2026: One-on-One meeting with Bank of America Securities

Business Update Neutral

2026-06-02 15:48

- PI Industries Limited will hold one-on-one interactions with Morgan Stanley on June 5, 2026, and Bank of America Securities on June 12, 2026, both in Mumbai. No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-02 15:45

- Investor Interactions Scheduled - June 5, 2026: One-on-One meeting with Morgan Stanley in Mumbai. - June 12, 2026: One-on-One meeting with Bank of America Securities in Mumbai. - No unpublished price sensitive information will be shared during these meetings.

Routine Neutral

2026-05-27 16:27

PI Industries Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by M/s. Makarand M. Joshi & Co., confirms that the company has complied with applicable SEBI Regulations and circulars/guidelines. No significant non-compliances, actions by SEBI or Stock Exchanges, or resignations of statutory auditors were observed during the review period.

Business Update Neutral

2026-05-26 16:29

PI Industries Limited announced one-on-one meetings with Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS on May 31, June 01, and June 09, 2026, respectively, in Mumbai. No unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-05-26 16:26

PI Industries Limited announced one-on-one interactions with institutional investors and broking houses, including Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS. These meetings are scheduled for May 31, June 01, and June 09, 2026, in Mumbai. The company confirmed that no unpublished price sensitive information will be shared during these interactions.

Business Update Neutral

2026-05-26 16:24

PI Industries Limited will interact with analysts/investors from Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS via one-on-one meetings on May 31, 2026, June 01, 2026, and June 09, 2026, respectively. The company has stated that no unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-05-26 16:23

PI Industries Limited has intimated about upcoming interactions with analysts and investors. The company will hold one-on-one meetings in Mumbai with Matthews International Capital Management on May 31, 2026, ICICI Prudential Asset Management Company on June 01, 2026, and ithought PMS on June 09, 2026. No unpublished price sensitive information is proposed to be shared during these meetings.

Business Update Neutral

2026-05-26 16:20

PI Industries Limited will hold one-on-one interactions with investors/analysts from Matthews International Capital Management (May 31, 2026), ICICI Prudential Asset Management Company (June 01, 2026), and ithought PMS (June 09, 2026) in Mumbai. No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-05-26 16:18

PI Industries Limited announced its schedule for interactions with analysts and institutional investors under Regulation 30(6) of SEBI (LODR) Regulations. The company will hold one-on-one meetings on May 31, June 01, and June 09, 2026, with Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS, respectively, in Mumbai. The company confirmed that no unpublished price sensitive information will be shared during these meetings.

Business Update Positive

2026-05-26 13:19

CRITICAL RED FLAG DETECTED

PI Industries reported FY26 consolidated revenue of ₹67,137 million with a healthy 25% EBITDA margin, supported by 40% growth in Pharma and over 20% in Biologicals, maintaining a debt-free balance sheet. For FY27, management guided for positive revenue growth, driven by recovery in AgChem exports (H2 FY27) and new product launches, including their first homegrown NCE, Pioxaniliprole. Capex is projected at ₹700-800 crore. The company targets ₹500-600 crore top line for Pharma to turn EBITDA positive in 2-3 years and $100 million revenue from Electronic Chemicals in 4-5 years, alongside significant growth from new biological products. Rajnish Sarna stepped down as JMD for health reasons but continues as a Non-Executive Director.

Business Update Positive

2026-05-26 13:09

Management guided for positive revenue growth in FY27, expecting late single-digit to early double-digit growth even in a worst-case scenario. This growth is anticipated to be driven by a recovery in exports, new product launches (including their first homegrown New Chemical Entity, Pioxaniliprole), and the scaling up of Pharma and Biologicals businesses. The Pharma segment is expected to achieve INR 500-600 crore revenue and turn EBITDA positive in 2-3 years, while Electronic Chemicals target ~$100 million revenue in 4-5 years. FY27 capex is guided at INR 700-800 crore. Despite the current global agrochemical downcycle and Q4 FY26 margin compression, the company maintained healthy FY26 consolidated EBITDA margins of 25% and remains debt-free with substantial cash, focusing on long-term innovation and diversification.

Business Update Neutral

2026-05-25 12:54

PI Industries Limited announced upcoming interactions with analysts and investors. The company will participate in the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026. These meetings will include one-on-one and group interactions at Grand Hyatt, Mumbai. The company confirmed that no unpublished price sensitive information will be shared.

Business Update Neutral

2026-05-25 12:52

PI Industries Limited informed about upcoming interactions with analysts and investors. The company will participate in the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026, both to be held at Grand Hyatt, Mumbai. The meetings will include a mix of one-on-one and group interactions. No unpublished price sensitive information is proposed to be shared.

PIIND

PI Industries Ltd

Price Chart

Filing History

Unlock Full History